US FDA declines to approve higher dose of Biogen's genetic disorder drug The U.S. Food and Drug Administration has declined to approve a higher-dose version of Biogen's drug for a rare genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback